期刊文献+

前置血管25例临床分析 被引量:10

Clinical Analysis of 25 Cases of Vasa Previa
下载PDF
导出
摘要 目的:探讨前置血管的孕期处理及围产儿结局。方法:收集2011年1月至2017年8月在北京大学第三医院分娩的25例前置血管患者的临床资料,回顾性分析其临床特点、孕期处理和围产儿结局。结果:(1)临床特征:25例前置血管患者占同期分娩产妇总数的0.8‰。患者年龄24~44岁,平均32.9±4.9岁。自然受孕20例(80.0%),体外受精-胚胎移植后受孕5例(20.0%);单胎22例(88.0%),双胎3例(12.0%)。孕期超声诊断15例(60.0%)并经分娩后胎盘检查证实,孕期超声检查未提示但分娩时诊断10例(40.0%)。帆状胎盘21例(84.0%),副胎盘4例(16.0%)。(2)孕期监测及处理:孕期超声诊断前置血管的15例患者中,14例于孕28~34周入院给予地塞米松促胎肺成熟,15例中13例因前置血管计划剖宫产分娩,2例因子痫前期、胎膜早破分别于孕34.8周和孕30.4周急诊剖宫产分娩。产时诊断前置血管的10例患者,5例择期剖宫产分娩,分娩孕周38.3~40.0周;4例因瘢痕子宫、先兆临产或胎膜早破、胎盘早剥急诊剖宫产分娩,分娩孕周36.0~39.3周;1例孕36.9周自然分娩。(3)围产儿结局:25例患者分娩活产儿28个,平均出生体质量2737.9±632.2 g。24例剖宫产分娩者均无新生儿窒息。仅1例患者孕36.9周阴道分娩,新生儿重度窒息。结论:孕期进行超声筛查大部分能产前明确前置血管诊断,孕28~32周收住院给予糖皮质激素促胎肺成熟,孕34~37周剖宫产终止妊娠,可获得良好的围产儿结局。 Objective:To study the treatment of vasa previa and outcome of perinatal infant. Methods:25 cases of vasa previa who admitted in Peking University third hospital from January 2011 to August 2017 were recruited. The clinical data,the management and perinatal outcome were analyzed retrospectively. Results:(1)Clinical features:25 patients with vasa previa accounted for 0.8%0 of the total number of births. The average age of patients was 32.9 ±4.9 years old. 15 patients(60. 0% ) were primiparas, 10 patients(40. 0% ) were pluriparas. 20 patients(80.0%) were conceived naturally,5 patients(20.0% ) were vitro fertilization. 22 patients(88.0% ) were single births,3 patients(12.0%) were twins. 15 patients(60%) were diagnosed by ultrasound antenatal, and confirmed by checking the placenta after delivery, 10 patients (40.0% ) were diagnosed intrapartum. 21 patients (84.0%) were velamentous cord insertion, 4 patients ( 16.0% ) were succenturiate placental lobe. (2)Monitoring and treatment during pregnancy: Among the 15 patients with antenatal diagnosed by ultrasound, 14 patients were admitted to the hospital with dexamethasone for the maturation of the fetal lung during 28 -34 weeks of pregnan- cy. Among them,13 cases were delivered by planning caesarean section, and 2 cases with pre-eclampsia and premature rupture of the membranes were delivered by the emergency caesarean section at 34.8 weeks and 30.4 weeks, respectively. 10 patients diagnosed intrapartum,5 patients had a planning caesarean section,and the delivery pregnancy week was 38. 3 -40. 0 weeks. 4 cases were delivered by the emergency caesarean section due to scar uterine, precursors, premature rupture of membranes, placental abruption, and delivery pregnancy week were 36. 0 -39.3 weeks. Another one patient was delivered by vagina at 36. 9 weeks. (3)Outcome of perinatal:There were 28 live births,the average quality of birth weight was 2737. 9 ±632. 2 g. No neonatal asphyxiation was found in 24 caesarean sections. Only one patient with a vaginal delivery at 36. 9 weeks,the newborn was severely asphyxia- ted. Conclusions: Patients with risk factors for vasa previa should receive ultrasound screening to clarify the diagnosis,28 -32 weeks gestation should admit to the hospital to recieve corticosteroids treatment to promote fetal lung maturity. Terminated by cesarean section during 34 -37 weeks,can obtain good perinatal outcome.
作者 郭晓玥 邵珲 赵扬玉 GUO Xiaoyue;SHAO Hui;ZHAO Yangyu(Peking University Third Hospital,Beijing 100191,China)
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2018年第7期519-522,共4页 Journal of Practical Obstetrics and Gynecology
关键词 前置血管 孕期处理 围产儿结局 Vasa previa Treatment Outcome of parinatal
  • 相关文献

参考文献1

二级参考文献21

  • 1Oppenheimer L, Society of Obstetricians and Gynaecologists ofCanada. Diagnosis and management of placenta previa. J ObstetGynaecol Can, 2007, 29:261-273.
  • 2Royal College of Obstetricians and Gynaecologists. Placentapraevia, placenta preavia accrete and vasa praevia diagnosis andmanagement. Green-top Guideline No. 27. January 2011 [ EB/OL]. [ 2012-06-18] http://www.rcog.org.uk/womens_health/clinical-guidance/ placenta-praevia-and-placenta-praevia-accreta~diagnosis-and-manageme.
  • 3Cho JY, Lee YH, Moon MH, et al. Difference in migration ofplacenta according to the location and type of placenta previa. JClin Ultrasound, 2008,36:79-84.
  • 4Rao KP, Belogolovkin Y, Yankowitz J, et al. Abnormalplacentation: evidence-based diagnosis and management oiplacenta previa, placenta accreta, and vasa previa. ObstetGynecol Surv, 2012, 67:503-519.
  • 5James KK, Steer PJ, Weiner CP, et al.高危妊娠.段涛,杨慧霞,译.3版.北京:人民卫生出版社,2008:1126.
  • 6Bose DA, Assel BG, Hill JB, et al. Maintenance tooolytics forpreterm symptomatic placenta previa : a review. Am J Perinatol,2011,28:45-50.
  • 7Sharma A, Suri V,Gupta I. Tocolytic therapy in conservalivemanagement of symptomatic placenta previa. Int J GynaecolObstet, 2004, 84:109-113.
  • 8Stafford IA, Dashe JS, Shivvers SA, et al. Ultrasonographiccervical length and risk of hemorrhage in pregnancies with placentaprevia. Obstet Gynecol, 2010 , 116:595-600.
  • 9Ohira S, Kikuchi N, Kobara H, et al. Predicting the route ofdelivery in women with low-lying placenta using transvaginalultrasonography : significance of placental migration and marginalsinus. Gynecol Obstet Invest,2012, 73 :217-222.
  • 10Oyelese Y. Placenta previa : the evolving role of ultrasound.Ultrasound Obstet Gynecol, 2009, 34 : 123-126.

共引文献303

同被引文献48

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部